Is titanium mesh cage safe in surgical management of pyogenic spondylitis?

• Published in: Journal of Korean Neurosurgical Society Vol. 50; no. 4; pp. 357 - 362
• Main Authors: Heo, Won, Kang, Dong Ho, Park, Kyung Bum, Hwang, Soo Hyun, Park, In Sung, Han, Jong Woo
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Neurosurgical Society 01.10.2011; 대한신경외과학회
• Subjects: Clinical; 신경외과학; Corpectomy; Titanium; Pyogenic spondylitis
• ISSN: 2005-3711; 1598-7876
• DOI: 10.3340/jkns.2011.50.4.357

To report our experience with pyogenic spondylitis treated with anterior radical debridement and insertion of a titanium mesh cage and to demonstrate the effectiveness and safety of the use of a titanium mesh cage in the surgical management of pyogenic spondylitis. We retrospectively analyzed the clinical characteristics of 19 patients who underwent surgical treatment in our department between January 2004 and December 2008. The average follow-up period was 11.16 months (range, 6-64 months). We evaluated risk factors, cultured organisms, lab data, clinical outcomes, and radiographic results. Surgical techniques for patients with pyogenic spondylitis were anterior radical debridement and reconstruction with titanium mesh cage insertion and screw fixation. All patients received intravenous antibiotics for at least 6 weeks postoperatively, and some patients received oral antibiotics. The infections resolved in all of the patients as noted by normalization of their erythrocyte sedimentation rates and C-reactive protein levels. The mean pain score on a Visual Analog Scale was 7.8 (range, 4-10) before surgery and 2.4 (range, 1-5) after surgery. The Frankel grade was improved by one grade in seven patients. After surgery, the average difference of the angle was improved about 6.96° in all patients. At the last follow-up, the mean loss of correction was 4.86°. Anterior radical debridement followed by the placement of instrumentation with a titanium mesh cage may be a safe and effective treatment for selected patients with pyogenic spondylitis. This surgical therapy does not lead to recurrent pyogenic spondylitis.